Funder
Department of Primary Care. Gerència Territorial de Barcelona. Catalan Institute of Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference36 articles.
1. Mcanally H, Bonnet U, Kaye AD. Gabapentinoid benefit and risk stratification: mechanisms over myth. Pain Ther. 2020;9(2):441–52. https://doi.org/10.1007/s40122-020-00189-x.
2. Lyrica: EPAR - Product information. 2009. https://www.ema.europa.eu/en/medicines/human/EPAR/lyrica. Accessed 1 Nov 2021
3. Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson van den JMBW. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study. PLoS Med. 2017;14:2396.
4. Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg. 2000;91(1):185–91. https://doi.org/10.1213/00000539-200007000-00035.
5. U.S. Food and Drug Administration. FDA warns about serious breathing problems seizure and nerve pain medicines gabapentin (neurontin, gralise, horizant) and pregabalin (lyrica, lyrica CR). 2017. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin. Accessed 1 Nov 2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献